Paradigm Capital Management Inc. NY decreased its position in shares of Masimo Corporation (NASDAQ:MASI) by 1.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 68,705 shares of the medical equipment provider’s stock after selling 1,300 shares during the quarter. Paradigm Capital Management Inc. NY owned about 0.13% of Masimo Corporation worth $5,947,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Prudential Financial Inc. raised its holdings in Masimo Corporation by 14.4% during the 2nd quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock worth $50,442,000 after purchasing an additional 69,810 shares during the last quarter. State Street Corp raised its holdings in Masimo Corporation by 10.4% during the 2nd quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock worth $141,121,000 after purchasing an additional 146,212 shares during the last quarter. American Century Companies Inc. raised its holdings in Masimo Corporation by 98.0% during the 2nd quarter. American Century Companies Inc. now owns 209,474 shares of the medical equipment provider’s stock worth $19,100,000 after purchasing an additional 103,656 shares during the last quarter. D L Carlson Investment Group Inc. raised its holdings in Masimo Corporation by 32.4% during the 2nd quarter. D L Carlson Investment Group Inc. now owns 46,240 shares of the medical equipment provider’s stock worth $4,216,000 after purchasing an additional 11,315 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its holdings in Masimo Corporation by 27.1% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock worth $99,872,000 after purchasing an additional 233,412 shares during the last quarter. Hedge funds and other institutional investors own 83.94% of the company’s stock.

In related news, Director Sanford Fitch sold 11,000 shares of Masimo Corporation stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total value of $959,750.00. Following the completion of the sale, the director now owns 72,249 shares of the company’s stock, valued at approximately $6,303,725.25. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Yongsam Lee sold 5,000 shares of Masimo Corporation stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $89.89, for a total transaction of $449,450.00. Following the completion of the sale, the executive vice president now directly owns 74,000 shares of the company’s stock, valued at approximately $6,651,860. The disclosure for this sale can be found here. In the last three months, insiders sold 39,976 shares of company stock valued at $3,559,074. 16.60% of the stock is currently owned by insiders.

Shares of Masimo Corporation (NASDAQ:MASI) traded down $2.59 during mid-day trading on Friday, hitting $86.49. 365,100 shares of the stock traded hands, compared to its average volume of 433,878. The firm has a market cap of $4,469.02, a P/E ratio of 33.14, a price-to-earnings-growth ratio of 2.91 and a beta of 0.75. Masimo Corporation has a one year low of $60.03 and a one year high of $104.71.

Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.17. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.17%. The business had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. During the same quarter last year, the firm posted $0.52 EPS. Masimo Corporation’s revenue was up 15.6% compared to the same quarter last year. analysts forecast that Masimo Corporation will post 2.96 earnings per share for the current fiscal year.

Several research analysts have issued reports on the stock. BidaskClub lowered shares of Masimo Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Roth Capital raised their price target on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Monday, August 14th. Stifel Nicolaus reaffirmed a “buy” rating and set a $108.00 price objective on shares of Masimo Corporation in a research report on Friday, November 3rd. Finally, Zacks Investment Research raised shares of Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 price objective for the company in a research report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $97.17.

ILLEGAL ACTIVITY NOTICE: “Paradigm Capital Management Inc. NY Reduces Position in Masimo Corporation (MASI)” was published by Watch List News and is owned by of Watch List News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/paradigm-capital-management-inc-ny-reduces-position-in-masimo-corporation-masi/1698115.html.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.